NEKTAR THERAPEUTICS

Historical 13F Holders

Symbol
NKTR
CUSIP
640268306
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 640268306 since 12/18/2024, largest first.

Filer % of Class Filed
FMR LLC 13G/A
15.0% 5/6/2026
Event 3/31/2026
Two Seas Capital LP 13G/A
9.8% 9/28/2026
Event 9/25/2026
BlackRock, Inc. 13G 7.8% 7/29/2026
Event 6/30/2026
Biotechnology Value Fund L P 13G/A
7.1% 8/14/2026
Event 6/30/2026
Vanguard Capital Management LLC 13G 5.2% 7/31/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
Susquehanna Securities, LLC 13G/A
4.0% 2/13/2026
Event 12/31/2025
Integrated Core Strategies (US) LLC 13G/A
3.0% 10/28/2025
Event 9/30/2025
Nantahala Capital Management, LLC 13G/A
2.2% 11/14/2025
Event 9/30/2025
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 4 3.35 M $203 M
2026 Q2 257 38.3 M $2.54 B
2026 Q1 222 26.9 M $1.94 B
2025 Q4 188 17.3 M $732 M
2025 Q3 164 14.4 M $820 M
2025 Q2 116 7.66 M $198 M
2023 Q1 1 33.0 $23.00
2022 Q4 1 33.0 $75.00
2022 Q3 1 33.0 $106.00
2022 Q2 1 33.0 $125.00
2022 Q1 1 33.0 $178.00
2021 Q4 1 33.0 $446.00
2021 Q3 1 33.0 $593.00
2021 Q2 1 33.0 $566.00
2021 Q1 1 33.0 $660.00
2020 Q4 1 33.0 $561.00
2020 Q3 1 33.0 $547.00
2020 Q2 1 33.0 $764.00
2020 Q1 1 33.0 $589.00
2019 Q4 1 33.0 $712.00
2019 Q3 1 17.0 $310.00
2019 Q1 1 17.0 $571.00
2018 Q4 1 17.0 $559.00
2018 Q3 1 17.0 $1.04 k
2018 Q2 1 17.0 $830.00
2018 Q1 1 17.0 $1.81 k